The NGAL Test is a particle-enhanced turbidimetric immunoassay for the quantitative determination of NGAL in human urine and plasma on automated clinical chemistry analyzers. NGAL measurements are useful in the risk assesment of AKI.
Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19 - ScienceDirect
News - Bioporto
Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury
Bioporto Human Elisa Kits - Diagnostic And Research Based at Rs 28000/kit in Hyderabad
Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19 - ScienceDirect
News - Bioporto
Home - Bioporto US
News - Bioporto
First Acute Kidney Injury Diagnostic Test Wins FDA Clearance - Research Horizons
Bioporto anmoder FDA om marketingsgodkendelse af NGAL-test — MedWatch
